Yale researchers have uncovered a way to make a type of white blood cells known as natural killer cells — which kill infected, damaged, or malignant cells in the body — more effective against cancer.

Researchers have made a breakthrough in cancer treatment by harnessing the disease-destroying abilities of the body’s natural killer cells. Their novel nanodrones selectively target a tumor, enabling ...

Acute Myeloid Leukemia (AML) remains one of the most challenging hematological malignancies to treat, with relapse and refractory cases continuing to pose significant hurdles. Traditional therapies ...

ANKL is a rare and aggressive type of blood cancer affecting a type of white blood cell called natural killer (NK) cells. In ANKL, the NK cells are abnormal and multiply out of control, crowding out ...

As part of a study published in January, 37 people who had been through various failed treatments for blood cancer received infusions of genetically enhanced immune cells that researchers hoped would ...

In a recent review published in the journal Nature, researchers collated available publications on natural killer (NK) cells – innate immune cells involved in recognizing and eliminating cells in ...

For years, chimeric antigen receptor (CAR) T cell therapies have led the way in cell-based immunotherapy, offering hope to many patients with certain blood cancers. But now, researchers believe the ...

A robust, ready-made and cell-based cancer therapy inches closer to reality in light of recent progress. Researchers at the MD Anderson Cancer Center released results from their Phase I/II clinical ...

A new comprehensive review reveals that harnessing natural killer (NK) cells by blocking their “off-switches” could significantly enhance cancer immunotherapy, providing new avenues for treating solid ...

Natural killer (NK) cells are the bodyguards of our immune system. As a first line of defense, they destroy invading pathogens, foreign bodies, and infected cells in early stages, thereby preventing ...